368 related articles for article (PubMed ID: 9437561)
61. Ultrasonographic and endocrine evaluation of ovarian function among Norplant implants users with regular menses.
Alvarez F; Brache V; Faundes A; Tejada AS; Thevenin F
Contraception; 1996 Nov; 54(5):275-9. PubMed ID: 8934060
[TBL] [Abstract][Full Text] [Related]
62. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Berenson AB; Wiemann CM
Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1128-35; discussion 1135-7. PubMed ID: 7726249
[TBL] [Abstract][Full Text] [Related]
63. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
[TBL] [Abstract][Full Text] [Related]
64. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
Haugen MM; Evans CB; Kim MH
J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
[TBL] [Abstract][Full Text] [Related]
65. [Norplant contraceptive implants: opinion of Dominican women who used this method].
Hardy E; Baez C; Faundes A; Alvarez F; Brache V
Acta Med Dom; 1990; 12(1):1-6. PubMed ID: 12292702
[TBL] [Abstract][Full Text] [Related]
66. Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants.
Brache V; Alvarez-Sanchez F; Faundes A; Tejada AS; Cochon L
Contraception; 1990 Feb; 41(2):169-77. PubMed ID: 2107058
[TBL] [Abstract][Full Text] [Related]
67. Condom practices of urban teens using Norplant contraceptive implants, oral contraceptives, and condoms for contraception.
Darney PD; Callegari LS; Swift A; Atkinson ES; Robert AM
Am J Obstet Gynecol; 1999 Apr; 180(4):929-37. PubMed ID: 10203661
[TBL] [Abstract][Full Text] [Related]
68. Depressive symptoms and Norplant contraceptive implants.
Westhoff C; Truman C; Kalmuss D; Cushman L; Rulin M; Heartwell S; Davidson A
Contraception; 1998 Apr; 57(4):241-5. PubMed ID: 9649915
[TBL] [Abstract][Full Text] [Related]
69. Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant).
Alvarez-Sanchez F; Brache V; de Oca VM; Cochon L; Faúndes A
Am J Obstet Gynecol; 2000 Mar; 182(3):535-9. PubMed ID: 10739504
[TBL] [Abstract][Full Text] [Related]
70. Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants.
Odlind V; Olsson SE
Contraception; 1986 Mar; 33(3):257-61. PubMed ID: 3087695
[TBL] [Abstract][Full Text] [Related]
71. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.
Berenson AB; Wiemann CM; Rickerr VI; McCombs SL
Am J Obstet Gynecol; 1997 Mar; 176(3):586-92. PubMed ID: 9077611
[TBL] [Abstract][Full Text] [Related]
72. Norplant implants in the UK: first year continuation and removals.
Peers T; Stevens JE; Graham J; Davey A
Contraception; 1996 Jun; 53(6):345-51. PubMed ID: 8773421
[TBL] [Abstract][Full Text] [Related]
73. The effects of reformulated 2-rod Norplant implant on hemostasis after three years.
Viegas OA; Koh SC; Ratnam SS
Contraception; 1996 Oct; 54(4):219-28. PubMed ID: 8922875
[TBL] [Abstract][Full Text] [Related]
74. Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users.
Pasquale SA; Knuppel RA; Owens AG; Bachmann GA
Contraception; 1994 Aug; 50(2):109-16. PubMed ID: 7956210
[TBL] [Abstract][Full Text] [Related]
75. A five-year evaluation of NORPLANT II implants in China.
Gu S; Du M; Zhang L; Liu Y; Wang S; Sivin I
Contraception; 1994 Jul; 50(1):27-34. PubMed ID: 7924320
[TBL] [Abstract][Full Text] [Related]
76. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
77. Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
Joshi UM; Joshi JV; Donde UM; Sankoli GM; Virkar KD; Saxena BN
Contraception; 1985 Jan; 31(1):71-82. PubMed ID: 3921309
[TBL] [Abstract][Full Text] [Related]
78. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
Affandi B; Cekan SZ; Boonkasemsanti W; Samil RS; Diczfalusy E
Contraception; 1987 Feb; 35(2):135-45. PubMed ID: 3109803
[TBL] [Abstract][Full Text] [Related]
79. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
80. A 5-year clinical evaluation of Norplant implants in Senegal.
Ba MG; Moreau JC; Sokal D; Dunson R; Dao B; Kouedou D; Diadhiou F
Contraception; 1999 Jun; 59(6):377-81. PubMed ID: 10518232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
